1st PanArab Congress of Liver Transplantation
Scientific Program
2006
First Day: Wednesday, March 8, 2006
08:00-09:00
REGISTRATION
09:15-10:00
OPENING CEREMONY

Holy Quran

President of the Congress
Ibrahim Mostafa

President of PAAG
Kasem Barada

President of PAAS
Medhat Sabet

President of MESOT
Faisal Shahin

Minister of Health and Population
H.E. Hatem El-Gabali
MESOT
–
PAAG
–
PAAS
4
1st PanArab Congress of Liver Transplantation
Scientific Program
10:00-12:10
2006
PLENARY I:
LIVER TRANSPLANTATION IN THE ARAB WORLD
CHAIRPERSONS:
 Adel Hosny
 Bandar Al-Knawy
 Farouk Ezzat
 Alaa Fayez
 Faleh Al-Faleh
SPEAKERS:
 King Faisal Specialist Hospital and Research Center, KSA
Mohamed Al-Sebayel
 Wady Al-Nile Hospital, Cairo, Egypt
Mahmoud El-Meteini
 King Abdulaziz Medical City, Riyadh, KSA
Abdul-Majeed Abdul-Kareem
 Dar Al-Fouad Hospital, Cairo, Egypt
 Riyadh Armed Forces Hospital, Riyadh, KSA
Atef Basas
 National Liver Institute (Egypt)
Ibrahim Marawan
(15 minutes each including discussion)
 Jordan
Abdallah Al-Bashir
 Mansoura (Egypt)
Gamal El-Ebeidy
 Kasr Al-Aini (Egypt)
Mostafa El-Shazly
 Algeria
Graba Abdelaziz
(10 minutes each including discussion)
MESOT
–
PAAG
–
PAAS
5
1st PanArab Congress of Liver Transplantation
Scientific Program
12:10-12:30
COFFEE BREAK
12:30-13:30
SYMPOSIUM
Dilemmas in Liver Transplantation
2006
CHAIRPERSONS:
 Alaa Ismail
 Ibrahim Al-Traif
 Omar Fathy
 Hatem Khalaf
 Mohamed Al-Sofayan
SPEAKERS:

INTRODUCTION TO LIVER TRANSPLANTATION FROM CADAVERIC
TO LIVING DONOR
Amr Helmy
 SURGICAL THERAPY OF LIVER TUMORS: LIVER RESECTION AND
LIVER TRANSPLANTATION
Massimo Malagó
 USE OF SMANCS FOR DOWENSTAGING OF HEPATOCELLULAR
CARCINOMA PRIOR TO LIVER TRANSPLANTATION
Khaled Greish
 SOLUTIONS FOR ORGAN SHORTAGE
Massimo Malagó
(15 minutes each including discussion)
Sponsored by Hoffmann La Roche Ltd.
13:30-15:00
LUNCH BREAK
MESOT
–
PAAG
–
PAAS
6
1st PanArab Congress of Liver Transplantation
Scientific Program
15:00-17:00
2006
FREE PAPERS I:
LIVER TRANSPLANT SURGERY
CHAIRPERSONS:
 Atef Basas
 Mahmoud El-Meteini
 Mohammed Al-Sebayel
 Ibrahim Marawan
 Mohamed Abdel-Wahab
SPEAKERS:
 THE FIRST 100 LIVE LIVER DONORS IN EGYPT: A SINGLE CENTER
EXPERIENCE
Alaa Hamza
 LDLT FOR HCC IN EGYPT
Mohamed Fathy
 RIGHT LOBE LIVING DONOR LIVER TRANSPLANTATION: SURGICAL
PITFALLS IN 112 CASES. WHERE DO WE STAND AFTER 7 YEARS?
Amr Abdelaal
 MANAGEMENT AND OUTCOME OF PORTAL VEIN THROMBOSIS
DURING ORTHOTOPIC OF LIVER TRANSPLANTATION
Khalid Abdullah
 ADULT TO ADULT LIVE DONOR LIVER TRANSPLANTATION: DONOR
MORBIDITY IN THE KING ABDULAZIZ MEDICAL CITY EXPERIENCE
Wael Ohali
 SPLIT LIVER TRANSPLANTATION FOR HEPATOCELLULAR
CARCINOMA
O. Omar
 SINGLE CENTER EXPERIENCE IN PEDIATRIC LIVER
TRANSPLANTATION
Hatem Saafan
 RETROSPECTIVE ANALYSIS OF THE CAUSES OF REJECTION OF
POTENTIAL DONORS FOR LIVING RELATED LIVER
TRANSPLANTATION
Khalid Abdullah
(15 minutes each including discussion)
MESOT
–
PAAG
–
PAAS
7
1st PanArab Congress of Liver Transplantation
Scientific Program
2006
Second Day: Thursday, March 9, 2006
09:30-10:30
SYMPOSIUM
Tarolimus in Liver Transplantation
CHAIRPERSONS:
 A. Abdul-Kareem
 Anwar Garad
 Mohammed Al-Saghier
 Abdullah Al-Basheer
 Medhat Abdel-Aal
SPEAKERS:
 SUPERIOR EFFICACY OF TAROLIMUS (PROGRAF) IN LIVER
TRANSPLANTATION
Olivier Boillot
 CASE PRESENTATION
Olivier Boillot
Sponsored by HIKMA Pharmaceuticals
10:30-12:30
PLENARY II:
EVOLVING EXPERIENCE IN THE ARAB WORLD
CHAIRPERSONS:
 Ali Al-Mehaidib
 Faisal Shahin
 Khalid Selim
 Ayman Abdo
 Ibrahim Mostafa
SPEAKERS:
 MANAGEMENT OF COMPLICATIONS OF CIRRHOSIS IN PATIENTS
AWAITING LIVER TRANSPLANTATION
Bandar Al-Knawy
 PATTERNS OF CHOLESTASIS IN SAUDI CHILDREN; BIOCHEMICAL
AND MOLECULAR APPROACH
Sami Wali
MESOT
–
PAAG
–
PAAS
8
1st PanArab Congress of Liver Transplantation
Scientific Program
2006
 FACTORS LIMITING THE EXPANSION OF THE TRANSPLANT
PROGRAM IN EGYPT
Imam Waked
 FOCAL AND SEGMENTAL GLOMERULOSCLEROSIS (FSGS) IS THE
COMMONEST GLOMERULAR LESION IN ORTHOTOPIC LIVER
TRANSPLANTATION (OLTX) RECIPIENTS ON TACROLIMUS. EARLY
CONVERSION TO CYCLOSPORINE (CSA) IN THIS SETTING DELAY
THE PROGRESSION OF THE GLOMERULAR LESION
Ali Al Lehbi
 TOURISM FOR LIVER TRANSPLANTION IN CHINA:A SINGLE SAUDI
CENTER EXPERIENCE
Mohammed Al-Saghier
 SPECTRUM OF CHILDHOOD LIVER DISEASES IN SAUDI ARABIA
Abullah Al-Zaben
(15 minutes each including discussion)
 THE ROLE OF TRANSPLANT CLINICAL PHARMACIST IN THE CARE
OF TRANSPLANT PATIENTS
Ahmed Aljedai
 COMBINED LIVING DONOR LIVER AND KIDNEY
TRANSPLANTATION FOR HYPEROXALURIA: KFSH&RC
EXPERIENCE
Hamad Al-Bahili
 ADVERSE EFFECTS OF SCHISTOSOMIASIS ON LIVER
TRANSPLANTATION
Om-Kolsom El-Haddad
(10 minutes each including discussion)
12:30-13:00
COFFEE BREAK
MESOT
–
PAAG
–
PAAS
9
1st PanArab Congress of Liver Transplantation
Scientific Program
13:00-14:00
2006
SYMPOSIUM
For Your Transplant Patients
Your Choice of Immunosuppressant May Matter
CHAIRPERSONS:
 Abdul-Jaleel Al-Awan
 M. Ramadan Baddar
 Saleh Mahmoud Saleh
 Ali Al-Lehbi
 Noaman El-Garem
SPEAKERS:
 THE BENEFIT OF CYCLOSPORINE IN TRANSPLANTATION
Gary A. Levy
(40 minutes including discussion)
 POST TRANSPLANT DIABETES MELLITUS & HYPERLIPEDEMIA:
EFFECTS OF HCV AND CALCINEURIN INHIBITORS
Rasha Refaie
 INCIDENCE OF DE NOVO HYPERTENSION IN PATIENTS
UNDERGOING LIVING DONOR LIVER TRANSPLANTATION AND ITS
RELATION TO THE TYPE OF IMMUNOSUPPRESSION
Wael Safwat
(10 minutes each including discussion)
Sponsored by NOVARTIS
14:00-15:30
LUNCH BREAK
MESOT
–
PAAG
–
PAAS
10
1st PanArab Congress of Liver Transplantation
Scientific Program
15:30-17:30
2006
FREE PAPERS II:
MULTIDISCIPLINARY PERSPECTIVES OF
LIVER TRANSPLANTATION
CHAIRPERSONS:
 Ahmed El-Dorry
 Hamad Al-Suhaibani
 Riyaz Ahmed
SPEAKERS:
 Amr Helmy
 Magda El-Monaiery
 Yehia Khater
 PROSTAGLANDIN E1 (ALPROSTADIL) INFUSION FOR
POSTOPERATIVE ICU MANAGEMENT OF POOR GRAFT FUNCTION
AFTER LIVER TRANSPLANTATION
Wafeeq Mahmood
 IMPACT OF PROPHYLACTIC ALPROSTADIL TREATMENT ON
PATIENTS OUTCOME AFTER LIVER TRANSPLANTATION
Sahar badawy
 SIGNIFICANCE OF CENTRILOBULAR NECROSIS IN LIVER
ALLOGRAFT BIOPSIES: CLINICAL PATHOLOGICAL CORRELATION
Muhammed Ashraf Ali
 MORPHOLOGIC EVIDENCE OF CHOLESTATSIS IN BIOPSIES FROM
LIVER ALLOGRAFTS: FREQUENCY AND ASSOCIATED FINDINGS
Mohammad Al-Omari
 MARKEDLY INCREASED SERUM CA19-9 IN AUTOIMMUNE
HEPATITIS DESPITE ABSENCE OF MALIGNANCY; WITH COMPLETE
NORMALIZATION AFTER LIVER TRANSPLANTATION
Yasser M. El-Sheikh
 THE ROLE OF RECOMBINANT FACTOR VII IN CONTROLLING THE
INTRAOPERATIVE BLOOD LOSS IN PATIENTS WITH SEVERE
COAGULOPATHY AND PORTAL HYPERTENSION DURING LIVING
DONOR LIVER TRANSPLANT SURGERY
Fawzia Aboul-Fetouh
(15 minutes each including discussion)
MESOT
–
PAAG
–
PAAS
11
1st PanArab Congress of Liver Transplantation
Scientific Program
2006
 BRAIN STEM POTENTIALS IN LIVER TRANSPLANTED CHILDREN
Magd Kotb
 THE VALUE OF ULTRASOUND IN EVALUATION OF POTENTIAL
LIVER DONORS
Eman Rewisha
 IMAGING TECHNIQUES IN PREOPERATIVE EVALUATION OF LIVING
DONOR FOR LIVER TRANSPLANTATION
Adel El-Bardrawy
(10 minutes each including discussion)
MESOT
–
PAAG
–
PAAS
12
1st PanArab Congress of Liver Transplantation
Scientific Program
2006
Poster Session
Poster Hall, March 8-9, All Day

IMPACT OF IMMUNOSUPPRESSION ON RECURRENCE OF HEPATITIS
C GENOTYPE IV IN LIVING DONOR LIVER TRANSPLANTATION
(PROSPECTIVE STUDY)
Ibrahim Mostafa

ACCURACY OF TWO DIFFERENT METHODS IN ESTIMATING THE
RIGHT GRAFT VOLUME FOR ADULT-TO-ADULT LIVING DONOR LIVER
TRANSPLANTATION
Hatem Khalaf

BILIARY COMPLICATIONS FOLLOWING CADAVERIC VERSUS LIVING
DONOR LIVER TRANSPLANTATION: KFSH&RC EXPERIENCE
Hatem Khalaf

THE IMPACT OF THE PRIMARY LIVER DISEASE ON THE EARLY
OUTCOME OF LIVING RELATED LIVER TRANSPLANTATION
Hatem Konsowa

CADAVERIC DONATION FOR LIVER TRANSPLANTATION: 5 YEARS
EXPERIENCE AT KFSH&RC, RIYADH, SAUDI ARABIA
Mohammed Al-Sebayel

DIAB M, STATINS AND CIRRHOTIC CARDIOMYOPATHY IN LIVER
TRANSPLANTATION
Abdel-Khalik Hamed

EARLY POST RIGHT LOBE LIVING RELATED LIVER TRANSPLANT
VENOUS OUTLET OBSTRUCTION TREATED WITH BALLOON
DILATATION FOLLOWED BY SEVERE ARDS: CASE REPORT
Mohammed Al-Saghier

ETHICAL DILEMMAS IN LIVER TRANSPLANTATION
Hatem Khalaf

HEPATITIS C RECURRENCE IN LIVING DONOR LIVER
TRANSPLANTATION VERSUS DECEASED DONOR LIVER
TRANSPLANTATION: PRELIMINARY DATA IN GENOTYPE 4
Mohammed Al-Sebayel
MESOT
–
PAAG
–
PAAS
13
1st PanArab Congress of Liver Transplantation
Scientific Program

2006
HIGH PREVALENCE OF OSTEOPENIA/OSTEOPOROSIS IN CIRRHOSIS
PATIENTS AWAITING LIVER TRANSPLANTATION
Ahmed Helmy

PEDIATRIC LIVER TRANSPLANTATION A 16 YEAR FOLLOW-UP OF 52
PATIENTS
Souheil M. Shabib

PROTOCOL LIVER BIOPSY FOR MACROVESICULAR STEATOSIS IN
THE EVALUATION OF LIVING DONORS WITH NORMAL BODY MASS
INDEX
Mohammed Al-Sebayel

RISK OF PROGRESSION OF NEUROWILSON’S DISEASE AFTER
ORTHOTOPIC LIVER TRANSPLANTATION (OLT): CASE REPORT
Mohammed Al-Saghier

SPONTANEOUS RECOVERY OF FULMINANT HEPATIC FAILURE DUE
TO PROPYL-THIO-URACIL IN AN 8 YEAR CHILD
Souheil M. Shabib

SUCCESSFUL LIVING RELATED DONOR KIDNEY TRANSPLANTATION
AFTER TREATMENT OF POST TRANSPLANT LYMPHOPROLIFERATIVE
DISORDER (PTLD) USING HUMANIZED ANTI-CD20 MONOCLONAL
ANTIBODY (RITUXIMAB)
Mohammed Al-Saghier

SURVIVAL FOLLOWING CADAVERIC VS LIVING DONOR LIVER
TRANSPLANTATION: A SINGLE CENTER EXPERIENCE
Mohammed Al-Sebayel

THE OUTCOME OF HEPATITIS C RECURRENCE ON ARAB ETHNIC
RACE: POST LIVER TRANSPLANTATION WITH GENOTYPE 1 AND 4
Mohammed Al-Saghier

A STUDY OF RISK FACTORS OF SPONTANEOUS BACTERIAL
PERITONITIS IN UPPER EGYPT
Shehata M
Thursday Night, December 9, 2006
GALA Dinner and Rewarding Ceremony
MESOT
–
PAAG
–
PAAS
14